Surgeons’ Ability to Predict the Extent of Surgery Prior to Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

BACKGROUND: The extent of surgery (ES) during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) is a well-known risk factor for major postoperative morbidity. Interestingly, the reliability of surgeons to predict the ES prior to CRS + HIPEC is unknown. METHODS: In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hentzen, Judith E. K. R., van der Plas, Willemijn Y., Been, Lukas B., Hoogwater, Frederik J. H., van Ginkel, Robert J., van Dam, Gooitzen M., Hemmer, Patrick H. J., Kruijff, Schelto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Peritoneal Surface Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334271/
https://www.ncbi.nlm.nih.gov/pubmed/32052304
http://dx.doi.org/10.1245/s10434-020-08237-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334271/
https://www.ncbi.nlm.nih.gov/pubmed/32052304
http://dx.doi.org/10.1245/s10434-020-08237-8

Ejemplares similares